NewsRx

Search our medical news database

AIDS Therapies (Remune)

New Antiviral Activity Reported

Published in AIDS Weekly, April 28th, 1997

The Immune Response Corp., Carlsbad, California, announced the company's data indicating Remune's effect on chemokine inducement.

The paper, "Effect of immunization with an inactivated gp120 depleted HIV-1 immunogen (Remune) on beta chemokine and cytokine production in subjects with HIV-1 infection" (JAIDS, April 1, 1997), is the first published report of an immune-based therapy for HIV infection increasing the production of chemokines and other potent antiviral factors.

It describes an open-label trial of 15 subjects, and suggests that immune cells of individuals immunized with Remune significantly increased their capacity to produce chemokines in...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook